semaglutide injection half life (A) Half-life extension mechanisms of acylated GLP-1 analogs. (B) Mean Enhanced plasma half-life and efficacy

Teva Pharmaceuticals

Semaglutide has demonstrated significant effectiveness in promoting weight loss

Each receptor it activates produces a distinct effect: GLP-1 receptor: suppresses appetite and slows digestion, reducing overall caloric intake GIP receptor: increases insulin sensitivity, supporting better glycemic control Glucagon receptor: boosts fat metabolism, driving energy expenditure independent of diet These three pathways point toward two outcomes: meaningful weight loss and improved glycemic control

Even if you are using this medication strictly for weight loss, stabilizing your blood sugar is the secret to sustained daily energy